Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine

Cell Metabolism

Volumn 25, Issue 3, 2017, Pages 572-579

  Nielsen, Jens ^a,b,c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b Technical University of Denmark   (Denmark)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

cancer; genome scale metabolic models; gut microbiome; N of 1 trials; stratification; systems medicine; type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; INSULIN;

DRUG TARGETING; GENOME SCALE METABOLIC MODEL; HUMAN; INSULIN RESISTANCE; MALIGNANT NEOPLASM; METABOLIC DISORDER; METABOLISM; METABOLOMICS; MODEL; NONALCOHOLIC FATTY LIVER; OBESITY; PERSONALIZED MEDICINE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; CELL FUNCTION; GENOME;

BIOMARKERS; CELL PHYSIOLOGICAL PHENOMENA; GENOME; HUMANS; METABOLISM; PRECISION MEDICINE; SYSTEMS BIOLOGY;

EID: 85014511212     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.02.002     Document Type: Review

References (61)

1. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., Nielsen, J., Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol., 8, 2012, e1002518.
2. Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., Nielsen, J., Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol., 10, 2014, 721.
3. Angermueller, C., Pärnamaa, T., Parts, L., Stegle, O., Deep learning for computational biology. Mol. Syst. Biol., 12, 2016, 878.
4. Ankerst, D.P., Liss, M., Zapata, D., Hoefler, J., Thompson, I.M., Leach, R.J., A case control study of sarcosine as an early prostate cancer detection biomarker. BMC Urol., 15, 2015, 99.
5. Arora, T., Bäckhed, F., The gut microbiota and metabolic disease: current understanding and future perspectives. J. Intern. Med. 280 (2016), 339–349.
6. Bar-Even, A., Noor, E., Savir, Y., Liebermeister, W., Davidi, D., Tawfik, D.S., Milo, R., The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry 50 (2011), 4402–4410.
7. Duarte, N.C., Becker, S.A., Jamshidi, N., Thiele, I., Mo, M.L., Vo, T.D., Srivas, R., Palsson, B.Ø., Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 104 (2007), 1777–1782.
8. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., Shlomi, T., Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol., 7, 2011, 501.
9. Gatto, F., Nookaew, I., Nielsen, J., Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma. Proc. Natl. Acad. Sci. USA 111 (2014), E866–E875.
10. Gatto, F., Miess, H., Schulze, A., Nielsen, J., Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism. Sci. Rep., 5, 2015, 10738.
11. Gatto, F., Schulze, A., Nielsen, J., Systematic analysis reveals that cancer mutations converge on deregulated metabolism of arachidonate and xenobiotics. Cell Rep. 16 (2016), 878–895.
12. Gatto, F., Volpi, N., Nilsson, H., Nookaew, I., Maruzzo, M., Roma, A., Johansson, M.E., Stierner, U., Lundstam, S., Basso, U., Nielsen, J., Glycosaminoglycan profiling in patients’ plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma. Cell Rep. 15 (2016), 1822–1836.
13. Gatto, F., Maruzzo, M., Magro, C., Basso, U., Nielsen, J., Prognostic value of plasma and urine glycosaminoglycan scores in clear cell renal cell carcinoma. Front. Oncol., 6, 2016, 253.
14. Gibbs, W.W., Medicine gets up close and personal. Nature 506 (2014), 144–145.
15. Gorden, D.L., Ivanova, P.T., Myers, D.S., McIntyre, J.O., VanSaun, M.N., Wright, J.K., Matrisian, L.M., Brown, H.A., Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS ONE, 6, 2011, e22775.
16. Gulsen, M., Yesilova, Z., Bagci, S., Uygun, A., Ozcan, A., Ercin, C.N., Erdil, A., Sanisoglu, S.Y., Cakir, E., Ates, Y., et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 20 (2005), 1448–1455.
17. Heinken, A., Thiele, I., Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework. Gut Microbes 6 (2015), 120–130.
18. Hood, L., Systems biology and p4 medicine: past, present, and future. Rambam Maimonides Med. J., 4, 2013, e0012.
19. Hood, L., Friend, S.H., Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8 (2011), 184–187.
20. Hood, L., Price, N.D., Demystifying disease, democratizing health care. Sci. Transl. Med., 6, 2014, 225ed5.
21. Jentzmik, F., Stephan, C., Lein, M., Miller, K., Kamlage, B., Bethan, B., Kristiansen, G., Jung, K., Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. J. Urol. 185 (2011), 706–711.
22. Karlsson, F., Tremaroli, V., Nielsen, J., Bäckhed, F., Assessing the human gut microbiota in metabolic diseases. Diabetes 62 (2013), 3341–3349.
23. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
24. Lee, S., Zhang, C., Kilicarslan, M., Piening, B.D., Bjornson, E., Hallström, B.M., Groen, A.K., Ferrannini, E., Laakso, M., Snyder, M., et al. Integrated network analysis reveals an association between plasma mannose levels and insulin resistance. Cell Metab. 24 (2016), 172–184.
25. Liebermeister, W., Noor, E., Flamholz, A., Davidi, D., Bernhardt, J., Milo, R., Visual account of protein investment in cellular functions. Proc. Natl. Acad. Sci. USA 111 (2014), 8488–8493.
26. Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., Goryanin, I., The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol., 3, 2007, 135.
27. Magnúsdóttir, S., Heinken, A., Kutt, L., Ravcheev, D.A., Bauer, E., Noronha, A., Greenhalgh, K., Jäger, C., Baginska, J., Wilmes, P., et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat. Biotechnol. 35 (2017), 81–89.
28. Mardinoglu, A., Nielsen, J., New paradigms for metabolic modeling of human cells. Curr. Opin. Biotechnol. 34 (2015), 91–97.
29. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., Walley, A.J., Froguel, P., Carlsson, L.M., Uhlen, M., Nielsen, J., Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol., 9, 2013, 649.
30. Mardinoglu, A., Kampf, C., Asplund, A., Fagerberg, L., Hallström, B.M., Edlund, K., Blüher, M., Pontén, F., Uhlen, M., Nielsen, J., Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J. Proteome Res. 13 (2014), 5106–5119.
31. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., Nielsen, J., Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun., 5, 2014, 3083.
32. Mardinoglu, A., Bjornson, E., Zhang, C., Adiels, M., Barrett, P.H.R., et al. Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD. Mol. Syst. Biol., 2016, 10.15252/msb.20167422 Published online March 2, 2017.
33. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9 (2009), 311–326.
34. Nilsson, A., Nielsen, J., Metabolic trade-offs in yeast are caused by F1F0-ATP synthase. Sci. Rep., 6, 2016, 22264.
35. O'Brien, E.J., Monk, J.M., Palsson, B.O., Using genome-scale models to predict biological capabilities. Cell 161 (2015), 971–987.
36. Palsson, B., Zengler, K., The challenges of integrating multi-omic data sets. Nat. Chem. Biol. 6 (2010), 787–789.
37. Patil, K.R., Nielsen, J., Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc. Natl. Acad. Sci. USA 102 (2005), 2685–2689.
38. Pfuntner, A., Wier, L.M., Elixhauser, A., Overview of Hospital Stays in the United States. HCUP Statistical Brief #166. 2011, Agency for Healthcare Research and Quality, Rockville, USA.
39. Psychogios, N., Hau, D.D., Peng, J., Guo, A.C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., et al. The human serum metabolome. PLoS ONE, 6, 2011, e16957.
40. Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527 (2015), 379–383.
41. Rhee, E.P., Ho, J.E., Chen, M.H., Shen, D., Cheng, S., Larson, M.G., Ghorbani, A., Shi, X., Helenius, I.T., O'Donnell, C.J., et al. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab. 18 (2013), 130–143.
42. Rhee, E.P., Yang, Q., Yu, B., Liu, X., Cheng, S., Deik, A., Pierce, K.A., Bullock, K., Ho, J.E., Levy, D., et al. An exome array study of the plasma metabolome. Nat. Commun., 7, 2016, 12360.
43. Schork, N.J., Personalized medicine: time for one-person trials. Nature 520 (2015), 609–611.
44. Shlomi, T., Cabili, M.N., Herrgård, M.J., Palsson, B.O., Ruppin, E., Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 26 (2008), 1003–1010.
45. Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R., Ruppin, E., Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Comput. Biol., 7, 2011, e1002018.
46. Shoaie, S., Karlsson, F., Mardinoglu, A., Nookaew, I., Bordel, S., Nielsen, J., Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci. Rep., 3, 2013, 2532.
47. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., et al., MICRO-Obes Consortium. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22 (2015), 320–331.
48. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
49. Sreekumar, A., Poisson, L.M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R.J., Li, Y., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 (2009), 910–914.
50. Suhre, K., Wallaschofski, H., Raffler, J., Friedrich, N., Haring, R., Michael, K., Wasner, C., Krebs, A., Kronenberg, F., Chang, D., et al. A genome-wide association study of metabolic traits in human urine. Nat. Genet. 43 (2011), 565–569.
51. Thiele, I., Fleming, R.M., Que, R., Bordbar, A., Diep, D., Palsson, B.O., Multiscale modeling of metabolism and macromolecular synthesis in E. coli and its application to the evolution of codon usage. PLoS ONE, 7, 2012, e45635.
52. Thiele, I., Swainston, N., Fleming, R.M.T., Hoppe, A., Sahoo, S., Aurich, M.K., Haraldsdottir, H., Mo, M.L., Rolfsson, O., Stobbe, M.D., et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31 (2013), 419–425.
53. Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. Proteomics. Tissue-based map of the human proteome. Science, 347, 2015, 1260419.
54. Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., Nookaew, I., Uhlén, M., Pedersen, B.K., Nielsen, J., Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. Cell Rep. 11 (2015), 921–933.
55. Vétizou, M., Pitt, J.M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
56. WHO. World Health Statistics 2011. 2011, World Health Organization, Geneva, Switzerland.
57. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. HMDB 3.0—The Human Metabolome Database in 2013. Nucleic Acids Res. 41 (2013), D801–D807.
58. Wu, H., Tremaroli, V., Bäckhed, F., Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol. Metab. 26 (2015), 758–770.
59. Yizhak, K., Chaneton, B., Gottlieb, E., Ruppin, E., Modeling cancer metabolism on a genome scale. Mol. Syst. Biol., 11, 2015, 817.
60. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
61. Zhao, X., Han, Q., Liu, Y., Sun, C., Gang, X., Wang, G., The relationship between branched-chain amino acid related metabolomics signature and insulin resistance: A systematic review. J. Diabetes Res. 2016 (2016), 1–12.